Enterprise Enablement

Tech-enabled HR, legal, and PMO platforms that standardize people operations and governance for biotech organizations.
Celito enables enterprises through standardized platforms and governance frameworks so scientists can focus on science. We deploy and operate standardized HR, legal, and portfolio platforms that help biotech organizations scale efficiently, remain compliant, and align execution to business outcomes.

Why Enterprise Enablement

Rapidly growing biotechs juggle complex HR needs, contract volumes, and cross-functional execution demands often on lean teams and manual workflows. Celito unifies best-of-breed platforms and standardized processes so you can hire faster, govern smarter, and deliver programs on time.

What We Deliver

HR & Talent Management

Contract Lifecycle & Legal Operations

Program & Portfolio Management Office (PMO)

Information & Document Management

Website & Enterprise App Operations

Our 4‑Step Methodology

Discover

Current‑state assessment and leadership alignment.

Design

Future‑state process mapping and requirements definition.

Implement

Platform configuration, data migration, and training.

Optimize

Continuous improvement sprints and KPI reporting.

Flexible Ways to Engage

Model
Typical Use Case
Commitment
G&A Application Programs
End‑to‑end enterprise systems deployment, integration, and operations.
Ongoing
G&A Systems Optimization Programs
Focused platform optimization for HR, CLM, or intranet environments.
Project‑based
Targeted Platforms Support
Targeted execution support for workflow automation and compliance tracking
As needed

Proven Outcomes

Optimized HR & contract workflows accelerate onboarding and vendor turnaround times by up to 30 %.

Centralized intranets cut information‑search time 20 % and boost cross‑team knowledge sharing.

Structured PMO dashboards improve project on‑time delivery rates by 25 % across portfolio initiatives.

Seamless integration of finance, HR, and legal systems reduces data‑entry errors and rework costs by 40 %.